Merrill Lynch sells Rs 1.90-cr shares of Matrix Labs

Merrill Lynch Capital Markets ESPANA has sold shares worth Rs 1.90 crore of the pharma company through an open market.

MUMBAI: Drug manufacturer Matrix Laboratories today said Merrill Lynch Capital Markets ESPANA has sold shares worth Rs 1.90 crore of the pharma company through an open market transaction.

Foreign fund house sold 2,15,810 shares worth Rs 1.90 crore, Matrix Laboratories said in a filing to the Bombay Stock Exchange.

Post selloff Merrill Lynch Capital Markets ESPANA now holds 3.43 per cent stake in Matrix Laboratories, the filing added.

Shares of Matrix Laboratories were trading at Rs 97.35, up 7.04 per cent on the BSE.
ADVERTISEMENT
READ MORE

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › News › Merrill Lynch sells Rs 1.90-cr shares of Matrix Labs
Text Size:AAA
Success
This article has been saved

*

+